Cardiorenal actions of endothelin, part II: Effects of cyclooxygenase inhibitors
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 46 (8) , 585-590
- https://doi.org/10.1016/0024-3205(90)90126-c
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Endothelin stimulates the release of prostacyclin from rat mesenteric arteriesBiochemical and Biophysical Research Communications, 1989
- Pharmacological modulation of the bronchopulmonary action of the vasoactive peptide, endothelin, administered by aerosol in the guinea-pigBiochemical and Biophysical Research Communications, 1989
- Endothelin-1 Releases Eicosanoids from Rabbit Isolated Perfused Kidney and SpleenJournal of Cardiovascular Pharmacology, 1989
- Integrated cardiac, renal, and endocrine actions of endothelin.Journal of Clinical Investigation, 1989
- The Modulation of Gastric Mucosal Integrity by Endothelin-1 and ProstacyclinJournal of Cardiovascular Pharmacology, 1989
- Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivoEuropean Journal of Pharmacology, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.Journal of Clinical Investigation, 1985
- Characterization of a coronary vasoconstrictor produced by cultured endothelial cellsAmerican Journal of Physiology-Cell Physiology, 1985
- Effect of prostaglandin synthetase inhibitors on renal blood flow in the ratAmerican Journal of Physiology-Legacy Content, 1976